Icaritin Alleviates Glutamate-Induced Neuronal Damage by Inactivating GluN2B-Containing NMDARs Through the ERK/DAPK1 Pathway

Overview

Journal Front Neurosci

Date 2021 Mar 11

PMID 33692666

Citations 11

Authors

Song Liu

Chaoming Liu

Lijiao Xiong

Jiali Xie

Cheng Huang

Rongbiao Pi

Zhihua Huang

Liangdong Li

Affiliations

Soon will be listed here.

Abstract

Excitatory toxicity due to excessive glutamate release is considered the core pathophysiological mechanism of cerebral ischemia. It is primarily mediated by N-methyl-D-aspartate receptors (NMDARs) on neuronal membranes. Our previous studies have found that icaritin (ICT) exhibits neuroprotective effects against cerebral ischemia in rats, but the underlying mechanism is unclear. This study aims to investigate the protective effect of ICT on glutamate-induced neuronal injury and uncover its possible molecular mechanism. An excitatory toxicity injury model was created using rat primary cortical neurons treated with glutamate and glycine. The results showed that ICT has neuroprotective effects on glutamate-treated primary cortical neurons by increasing cell viability while reducing the rate of lactate dehydrogenase (LDH) release and reducing apoptosis. Remarkably, ICT rescued the changes in the ERK/DAPK1 signaling pathway after glutamate treatment by increasing the expression levels of p-ERK, p-DAPK1 and t-DAPK1. In addition, ICT also regulates NMDAR function during glutamate-induced injury by decreasing the expression level of the GluN2B subunit and enhancing the expression level of the GluN2A subunit. As cotreatment with the ERK-specific inhibitor U0126 and ICT abolishes the beneficial effects of ITC on the ERK/DAPK1 pathway, NMDAR subtypes and neuronal cell survival, ERK is recognized as a crucial mediator in the protective mechanism of ICT. In conclusion, our findings demonstrate that ICT has a neuroprotective effect on neuronal damage induced by glutamate, and its mechanism may be related to inactivating GluN2B-containing NMDAR through the ERK/DAPK1 pathway. This study provides a new clue for the prevention and treatment of clinical ischemic cerebrovascular diseases.

Citing Articles

The underlying mechanism of calcium toxicity-induced autophagic cell death and lysosomal degradation in early stage of cerebral ischemia.

Sengking J, Mahakkanukrauh P Anat Cell Biol. 2024; 57(2):155-162.

PMID: 38680098 PMC: 11184419. DOI: 10.5115/acb.24.003.

Quercetin attenuated ischemic stroke induced neurodegeneration by modulating glutamatergic and synaptic signaling pathways.

Shah F, Albaqami F, Alattar A, Alshaman R, Zaitone S, Gabr A Heliyon. 2024; 10(7):e28016.

PMID: 38571617 PMC: 10987936. DOI: 10.1016/j.heliyon.2024.e28016.

N-Ethyl-N-Nitrosourea Induced Leukaemia in a Mouse Model: Protective Effect of Icaritin via Inhibition of IL-6/JAK2/STAT3 Pathway Causes Apoptosis.

Hou X, Han Y, Hirad A, Alarfaj A, Liu L J Inflamm Res. 2024; 17:777-790.

PMID: 38344310 PMC: 10859094. DOI: 10.2147/JIR.S441755.

Icaritin Promotes Myelination by Simultaneously Enhancing the Proliferation and Differentiation of Oligodendrocyte Precursor Cells.

Yang F, Wen H, Ma S, Chang Q, Pan R, Liu X Molecules. 2023; 28(15).

PMID: 37570807 PMC: 10421464. DOI: 10.3390/molecules28155837.

NMDARs antagonist MK801 suppresses LPS-induced apoptosis and mitochondrial dysfunction by regulating subunits of NMDARs via the CaM/CaMKII/ERK pathway.

Han W, Hao X, Hong Y, Zhao S, Chen X, Wang R Cell Death Discov. 2023; 9(1):59.

PMID: 36774369 PMC: 9922289. DOI: 10.1038/s41420-023-01362-9.

References

Liu P, Jin X, Lv H, Li J, Xu W, Qian H . Icaritin ameliorates carbon tetrachloride-induced acute liver injury mainly because of the antioxidative function through estrogen-like effects. In Vitro Cell Dev Biol Anim. 2014; 50(10):899-908. DOI: 10.1007/s11626-014-9792-8. View

Liu L, Zhao Z, Lu L, Liu J, Sun J, Dong J . Icariin and icaritin ameliorated hippocampus neuroinflammation via mediating HMGB1 expression in social defeat model in mice. Int Immunopharmacol. 2019; 75:105799. DOI: 10.1016/j.intimp.2019.105799. View

Zhao P, Yang J, Wang Y, Hao Y, Li Y, Li N . Neuroprotection of Cytisine Against Cerebral Ischemia-Reperfusion Injury in Mice by Regulating NR2B-ERK/CREB Signal Pathway. Neurochem Res. 2018; 43(8):1575-1586. DOI: 10.1007/s11064-018-2572-1. View

Zhang L, Li Y, Lan L, Liu R, Wu Y, Qu Q . Tamoxifen has a proliferative effect in endometrial carcinoma mediated via the GPER/EGFR/ERK/cyclin D1 pathway: A retrospective study and an in vitro study. Mol Cell Endocrinol. 2016; 437:51-61. DOI: 10.1016/j.mce.2016.08.011. View

Amantea D, Bagetta G . Excitatory and inhibitory amino acid neurotransmitters in stroke: from neurotoxicity to ischemic tolerance. Curr Opin Pharmacol. 2017; 35:111-119. DOI: 10.1016/j.coph.2017.07.014. View

Tu W, Xu X, Peng L, Zhong X, Zhang W, Soundarapandian M . DAPK1 interaction with NMDA receptor NR2B subunits mediates brain damage in stroke. Cell. 2010; 140(2):222-34. PMC: 2820131. DOI: 10.1016/j.cell.2009.12.055. View

Zhang K, Li Y, Yang Q, Gerile O, Yang L, Li X . Neuroprotective effects of oxymatrine against excitotoxicity partially through down-regulation of NR2B-containing NMDA receptors. Phytomedicine. 2012; 20(3-4):343-50. DOI: 10.1016/j.phymed.2012.10.018. View

Mukherjee D, Patil C . Epidemiology and the global burden of stroke. World Neurosurg. 2011; 76(6 Suppl):S85-90. DOI: 10.1016/j.wneu.2011.07.023. View

Xiong W, Wu Y, Xian W, Song L, Hu L, Pan S . DAPK1-ERK signal mediates oxygen glucose deprivation reperfusion induced apoptosis in mouse N2a cells. J Neurol Sci. 2018; 387:210-219. DOI: 10.1016/j.jns.2018.01.003. View

10.

Zheng M, Qu L, Lou Y . Effects of icariin combined with Panax notoginseng saponins on ischemia reperfusion-induced cognitive impairments related with oxidative stress and CA1 of hippocampal neurons in rat. Phytother Res. 2008; 22(5):597-604. DOI: 10.1002/ptr.2276. View

11.

Zhu H, Wang Z, Zhu X, Wu X, Li E, Xu Y . Icariin protects against brain injury by enhancing SIRT1-dependent PGC-1alpha expression in experimental stroke. Neuropharmacology. 2010; 59(1-2):70-6. DOI: 10.1016/j.neuropharm.2010.03.017. View

12.

Yuan H, Myers S, Wells G, Nicholson K, Swanger S, Lyuboslavsky P . Context-dependent GluN2B-selective inhibitors of NMDA receptor function are neuroprotective with minimal side effects. Neuron. 2015; 85(6):1305-1318. PMC: 4368485. DOI: 10.1016/j.neuron.2015.02.008. View

13.

Wu Y, Xia L, Zhou Y, Xu Y, Jiang X . Icariin induces osteogenic differentiation of bone mesenchymal stem cells in a MAPK-dependent manner. Cell Prolif. 2015; 48(3):375-84. PMC: 6496185. DOI: 10.1111/cpr.12185. View

14.

Hardingham G, Bading H . Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat Rev Neurosci. 2010; 11(10):682-96. PMC: 2948541. DOI: 10.1038/nrn2911. View

15.

Fan H, Li X, Wang W, Lai Q, Tang X, Gao D . Effects of NMDA-Receptor Antagonist on the Expressions of Bcl-2 and Bax in the Subventricular Zone of Neonatal Rats with Hypoxia-Ischemia Brain Damage. Cell Biochem Biophys. 2016; 73(2):323-330. DOI: 10.1007/s12013-015-0586-8. View

16.

Wang S, Shi X, Li H, Pang P, Pei L, Shen H . DAPK1 Signaling Pathways in Stroke: from Mechanisms to Therapies. Mol Neurobiol. 2016; 54(6):4716-4722. PMC: 5509806. DOI: 10.1007/s12035-016-0008-y. View

17.

Liu S, Zhang N, Guo Y, Zhao R, Shi T, Feng S . G-protein-coupled receptor 30 mediates rapid neuroprotective effects of estrogen via depression of NR2B-containing NMDA receptors. J Neurosci. 2012; 32(14):4887-900. PMC: 6620914. DOI: 10.1523/JNEUROSCI.5828-11.2012. View

18.

Wu Z, Ou L, Wang C, Yang L, Wang P, Liu H . Icaritin induces MC3T3-E1 subclone14 cell differentiation through estrogen receptor-mediated ERK1/2 and p38 signaling activation. Biomed Pharmacother. 2017; 94:1-9. DOI: 10.1016/j.biopha.2017.07.071. View

19.

Qin S, Zhou W, Liu S, Chen P, Wu H . Icariin stimulates the proliferation of rat bone mesenchymal stem cells via ERK and p38 MAPK signaling. Int J Clin Exp Med. 2015; 8(5):7125-33. PMC: 4509195. View

20.

Goodell D, Zaegel V, Coultrap S, Hell J, Bayer K . DAPK1 Mediates LTD by Making CaMKII/GluN2B Binding LTP Specific. Cell Rep. 2017; 19(11):2231-2243. PMC: 5549467. DOI: 10.1016/j.celrep.2017.05.068. View